Fibromodulin (encoded by FMOD) is thought to be involved in the inhibition of tumorigenesis and apoptosis in hematologic malignancies such as B-cell chronic lymphocytic leukemia and mantle cell lymphoma, like other proteoglycans (40). The gene discussed is FMOD; the disease is B-cell chronic lymphocytic leukemia.